# Lecture 10: Atypical Bacteria
## Unit 2.8: Microbiology
---
## Learning Objectives
By the end of this lecture, students will be able to:
1. Describe the unique characteristics of atypical bacteria
2. Explain Chlamydia species and their clinical syndromes
3. Describe Rickettsia and rickettsial diseases
4. Explain Mycoplasma and related organisms
5. Describe spirochetes (Treponema, Borrelia, Leptospira)
6. Explain the diagnosis and treatment of atypical bacterial infections
---
## Lecture Outline
### I. Overview of Atypical Bacteria
The designation "atypical bacteria" encompasses a diverse group of prokaryotic organisms unified by their failure to conform to conventional bacteriologic expectations, particularly their inability to be visualized by standard Gram staining and their resistance to cultivation on routine laboratory media. These organisms challenge traditional definitions of bacteria through various mechanisms: some lack cell walls entirely, others exist obligately within host cells unable to replicate extracellularly, and still others possess unique morphologies requiring specialized visualization techniques. The clinical importance of atypical bacteria far exceeds their laboratory challenges, as they cause some of the most common and most serious infectious diseases encountered in medical practice. Understanding their unique biology directly informs diagnostic approaches and treatment selection, as conventional antibiotic targets may be absent or inaccessible.
The classification of atypical bacteria reflects their distinct biological characteristics rather than phylogenetic relationships. Obligate intracellular bacteria include Chlamydia species, which depend entirely on host cells for energy and replication, as well as Rickettsia, Ehrlichia, Anaplasma, and Coxiella, which similarly require the intracellular environment for survival. Wall-less bacteria, exemplified by Mycoplasma and Ureaplasma, lack peptidoglycan cell walls entirely, instead possessing cholesterol-containing membranes that render them inherently resistant to beta-lactam antibiotics. The spirochetes comprise bacteria with distinctive helical morphology including Treponema, Borrelia, and Leptospira, each causing characteristic clinical syndromes. These organisms share the common feature of requiring specialized diagnostic approaches beyond routine culture, though they differ substantially in pathogenic mechanisms and clinical presentations.
The clinical importance of atypical bacteria derives from their prevalence as causes of common infections and their role in serious, potentially life-threatening diseases. Chlamydia trachomatis represents the most common bacterial sexually transmitted infection in developed countries, while Mycoplasma pneumoniae accounts for a substantial proportion of community-acquired pneumonia, particularly in younger populations. Rickettsial diseases, though less common, demand recognition because delayed treatment of Rocky Mountain spotted fever carries significant mortality. Syphilis, caused by Treponema pallidum, remains a major global health challenge with rising incidence in many populations. Lyme disease caused by Borrelia burgdorferi has become the most common vector-borne disease in temperate regions. The diagnostic challenges posed by these organisms mandate clinical recognition of characteristic syndromes that prompt appropriate testing.
The culture requirements of atypical bacteria directly influence diagnostic strategies and explain why many infections are diagnosed through indirect methods. Chlamydia species require cell culture for isolation, making nucleic acid amplification tests (NAAT) the standard diagnostic approach for C. trachomatis; serology serves for C. pneumoniae and C. psittaci. Rickettsia species require biosafety level 3 containment for culture, rendering serology and clinical diagnosis the practical approaches. Mycoplasma species grow on specialized media but require prolonged incubation; PCR has largely supplanted culture for diagnosis. Spirochetes present varying challenges: Treponema pallidum cannot be cultured in vitro at all, Borrelia species require special media with limited success, and Leptospira culture requires weeks of incubation. Consequently, serologic testing, molecular methods, and direct visualization using dark-field microscopy assume primary diagnostic roles for these organisms.
Panel A: Atypical bacteria classification diagram - central hub labeled "Atypical Bacteria" with three main branches: obligate intracellular organisms (Chlamydia, Rickettsia, Ehrlichia, Anaplasma, Coxiella shown within host cells), wall-less bacteria (Mycoplasma, Ureaplasma shown as irregular cells without wall), and spirochetes (Treponema, Borrelia, Leptospira shown in helical morphology).
Panel B: Why they don't Gram stain - four panels showing failed Gram stain attempts with explanations: Chlamydia (too small, minimal peptidoglycan), Rickettsia (small size, intracellular location), Mycoplasma (no cell wall to retain stain), spirochetes (too thin for light microscopy visualization), each with microscopy comparison showing actual visualization method.
Panel C: Clinical importance pyramid - base showing common infections (Chlamydia STI, Mycoplasma pneumonia), middle tier showing serious diseases (RMSF, syphilis, Lyme), apex showing diagnostic challenges (special tests required), with treatment theme (macrolides/doxycycline) spanning all levels.
Panel D: Culture requirements comparison table - four rows showing each organism group with corresponding culture needs (cell culture for Chlamydia, BSL-3 for Rickettsia, special media/slow for Mycoplasma, dark-field/special media/serology for spirochetes), with practical diagnostic alternative listed for each.
---
### II. Chlamydia - General
Chlamydia species represent remarkable bacterial pathogens that have evolved obligate intracellular parasitism to an extreme degree, depending entirely on host cells for the energy and biosynthetic intermediates necessary for replication. These organisms are among the smallest bacteria, measuring only 0.2-0.4 micrometers, which combined with their lack of typical peptidoglycan explains their failure to retain Gram stain. The term "energy parasites" aptly describes Chlamydia, as they possess transporters for host ATP and other high-energy compounds rather than generating their own through independent metabolism. This obligate intracellular lifestyle necessitates specialized diagnostic approaches, as these organisms cannot be grown on conventional agar plates; historically cell culture was required, though molecular detection has now become standard.
The developmental cycle of Chlamydia represents one of the most distinctive features of these organisms, involving alternation between two morphologically and functionally distinct forms. The elementary body (EB) represents the infectious form, small and metabolically inert, adapted for extracellular survival and transmission between hosts; its condensed chromatin and rigid outer membrane structure enable resistance to environmental stresses. The reticulate body (RB) is the intracellular, metabolically active form that replicates within host cells; larger and more fragile than the EB, it is adapted for nutrient acquisition and binary fission within the protected intracellular environment. This biphasic cycle explains both the infectious nature of the organism and its vulnerability within the host cell.
The complete developmental cycle of Chlamydia proceeds through defined stages within the host cell over approximately 48-72 hours. The cycle begins when an EB attaches to host cell surface receptors, triggering receptor-mediated endocytosis into a membrane-bound vacuole that will become the characteristic inclusion body. Within 6-8 hours, the EB converts to the larger RB form within this protected compartment, which the organism prevents from fusing with lysosomes. The RB then undergoes repeated binary fission, with the expanding inclusion body eventually occupying much of the host cell cytoplasm and containing hundreds of organisms. As the inclusion matures, RBs convert back to EBs, and the cycle concludes with host cell lysis and release of infectious EBs, or sometimes by extrusion of intact inclusions, allowing spread to new cells.
Multiple virulence factors enable Chlamydia species to establish and maintain their intracellular parasitic lifestyle. The major outer membrane protein (MOMP) serves as the primary surface adhesin mediating attachment to host cells and represents a major target of host immune responses; MOMP variation creates the serological diversity underlying different serovars. A type III secretion system injects effector proteins into host cells, manipulating cellular processes to favor chlamydial survival and replication. Critical among these effects is the inhibition of host cell apoptosis, prolonging cell survival to allow completion of the developmental cycle. The prevention of phagolysosome fusion protects intracellular organisms from degradation, while recruitment of host lipids and nutrients to the inclusion membrane supports replication.
Panel A: Elementary body versus reticulate body comparison - side-by-side electron microscopy appearance with labeled features: EB (small 0.3 micrometers, condensed DNA, rigid membrane, "infectious/inert"), RB (larger 1 micrometer, dispersed DNA, fragile membrane, "replicative/active"), with arrow showing transformation between forms.
Panel B: Developmental cycle circular diagram - host cell with inclusion body in center, stages arranged clockwise: EB attachment and entry (0 hours), EB to RB conversion (6-8 hours), RB replication expanding inclusion (12-48 hours), RB to EB conversion (48-72 hours), release by lysis or extrusion, with time stamps at each stage.
Panel C: Inclusion body microscopy - host cell with multiple inclusion bodies shown by fluorescent staining, progression from small early inclusion to large mature inclusion with hundreds of organisms, comparison of Giemsa staining appearance (basophilic intracytoplasmic inclusions).
Panel D: Virulence factor diagram - Chlamydia within inclusion body with labeled mechanisms: MOMP on surface (adhesion), type III secretion needle injecting effectors, apoptosis inhibition (crossed-out apoptosis signal), phagolysosome fusion block (lysosome unable to fuse with inclusion), and lipid/nutrient recruitment to inclusion membrane.
---
### III. Chlamydia trachomatis
Chlamydia trachomatis demonstrates remarkable diversity in the diseases it causes, with different serovars (serological variants based on MOMP) producing distinct clinical syndromes ranging from blinding trachoma to sexually transmitted infections to invasive lymphogranuloma venereum. Serovars A through C cause trachoma, a chronic conjunctival infection endemic in developing regions that remains the world's leading infectious cause of preventable blindness. Serovars D through K cause the common urogenital infections and neonatal disease acquired during birth, representing the predominant strains in developed countries. Serovars L1, L2, and L3 cause lymphogranuloma venereum (LGV), a more invasive sexually transmitted infection that spreads to regional lymph nodes, causing suppurative lymphadenitis and potentially severe sequelae.
Urogenital chlamydial infection represents the most common bacterial sexually transmitted infection in the United States and many developed countries, with particularly high prevalence among sexually active young adults. In females, cervicitis represents the primary manifestation, though the infection is asymptomatic in approximately 70-80% of cases; symptoms when present include vaginal discharge and intermenstrual bleeding. Untreated infection may ascend to cause pelvic inflammatory disease (PID), with consequences including tubal scarring, infertility, and increased risk of ectopic pregnancy. In males, urethritis presents with mucoid or mucopurulent urethral discharge and dysuria, though many infections are asymptomatic; epididymitis may complicate ascending infection. Chlamydial infection, along with other bacterial STIs, is a cause of reactive arthritis (formerly Reiter syndrome), manifesting as arthritis, urethritis, and conjunctivitis following genitourinary infection.
Trachoma remains endemic in parts of Africa, Asia, and the Middle East, where it causes significant visual impairment and blindness through a process of repeated infection and scarring. Initial infection causes follicular conjunctivitis that may resolve spontaneously, but repeated infections in endemic areas trigger progressive scarring of the conjunctival surface. Scarring distorts the eyelid margin, causing trichiasis, the turning inward of eyelashes, which then abrade the cornea with each blink. Progressive corneal scarring and opacification ultimately result in blindness. The World Health Organization's SAFE strategy addresses trachoma through Surgery for trichiasis, Antibiotic distribution (azithromycin mass treatment), Face washing to reduce transmission, and Environmental improvement including access to clean water and sanitation.
Neonatal chlamydial infection occurs when infants are exposed to C. trachomatis during passage through an infected birth canal, with infection rates approaching 50% among exposed newborns. Inclusion conjunctivitis typically presents 5-14 days after birth with purulent conjunctival discharge and eyelid swelling; unlike gonococcal ophthalmia, which presents within the first few days, chlamydial conjunctivitis has a later onset. If untreated, eye infection rarely causes permanent damage but signals potential respiratory tract colonization. Chlamydial pneumonia presents between 1 and 3 months of age with a distinctive staccato cough, tachypnea, and lack of fever; chest radiography shows bilateral infiltrates, and peripheral eosinophilia is common. Prevention through prenatal screening and treatment of pregnant women effectively reduces neonatal transmission.
Panel A: C. trachomatis serovar disease map - three boxes showing serovar groups (A-C, D-K, L1-L3) with associated diseases (trachoma with eye illustration, urogenital infections with anatomic diagram, LGV with lymph node involvement), and geographic/demographic associations for each.
Panel B: Urogenital infection pathways - split panel for female (cervix with cervicitis, ascending to PID with tubal involvement, complications listed: infertility, ectopic pregnancy) and male (urethritis with discharge, epididymitis), plus reactive arthritis triad (arthritis, urethritis, conjunctivitis) shown below.
Panel C: Trachoma progression sequence - five stages: initial follicular conjunctivitis, repeated infection with progressive scarring, trichiasis with inturned lashes, corneal abrasion from lash contact, and final corneal opacity with blindness; SAFE strategy components illustrated around the sequence.
Panel D: Neonatal infection timeline - birth at left, inclusion conjunctivitis onset at 5-14 days (purulent discharge photo), pneumonia onset at 1-3 months (staccato cough icon, afebrile noted, CXR with bilateral infiltrates), with prevention strategy (prenatal screening and treatment) highlighted.
---
### IV. Other Chlamydia Species
Chlamydia pneumoniae, also known by its historical designation TWAR (from laboratory isolates Taiwan and Acute Respiratory), causes respiratory tract infections transmitted between humans through respiratory droplets without animal reservoir involvement. This species has been implicated in 5-10% of community-acquired pneumonia cases, with higher rates during outbreaks, and serologic surveys suggest that most adults have been infected at some point in their lives. Clinical presentation typically includes pharyngitis with hoarseness as a prodrome, followed by a persistent, nonproductive cough that may continue for weeks to months. The pneumonia is generally mild, resembling other causes of "atypical" pneumonia, with ambulatory patients showing minimal hypoxia despite radiographic infiltrates. Chronic infection has been associated in some studies with atherosclerosis and coronary artery disease, though the causal relationship remains unproven.
Chlamydia psittaci causes psittacosis (also called ornithosis), a zoonotic infection acquired through inhalation of aerosolized dried bird droppings, respiratory secretions, or feather dust from infected birds. Psittacine birds (parrots, parakeets, cockatiels) are classic reservoirs, though infection occurs with exposure to many bird species including pigeons, turkeys, and ducks. Occupational exposure affects pet shop workers, veterinarians, poultry workers, and bird breeders, while household exposure through pet birds represents another common source. The clinical syndrome includes severe pneumonia with high fever, headache, and often hepatosplenomegaly; relative bradycardia despite fever (pulse-temperature dissociation) may occur. A history of bird exposure represents a critical diagnostic clue that should prompt consideration of this diagnosis in patients with atypical pneumonia.
Diagnosis of chlamydial infections employs different methods depending on the species and clinical syndrome. For C. trachomatis urogenital infection, nucleic acid amplification testing (NAAT) on urine or genital swabs has become the standard of care, offering sensitivity and specificity superior to culture while enabling noninvasive sampling. NAAT can also detect C. trachomatis in conjunctival specimens for trachoma diagnosis. For C. pneumoniae and C. psittaci, serology remains the most commonly used diagnostic method, though PCR is increasingly available; a fourfold rise in antibody titer between acute and convalescent specimens confirms diagnosis. Cell culture, historically the gold standard, requires specialized laboratory capabilities and has largely been replaced by molecular methods. Giemsa or iodine staining of infected cells to visualize intracellular inclusion bodies has historical interest but is insensitive compared to modern methods.
Treatment of chlamydial infections exploits the protein synthesis-dependent nature of these intracellular organisms, with antibiotics that penetrate cells and concentrate intracellularly. For uncomplicated urogenital C. trachomatis infection, azithromycin as a single 1-gram oral dose provides the advantage of directly observed therapy ensuring compliance; alternatively, doxycycline for 7 days is equally effective. Lymphogranuloma venereum requires prolonged therapy with doxycycline for 21 days due to deeper tissue involvement. Respiratory chlamydial infections (C. pneumoniae, C. psittaci) respond to azithromycin, doxycycline, or respiratory fluoroquinolones. Neonatal chlamydial conjunctivitis and pneumonia are treated with erythromycin, as doxycycline and fluoroquinolones are contraindicated in infants. Partner treatment for STIs is essential to prevent reinfection, with expedited partner therapy providing medication to sexual partners without examination when permitted by local regulations.
Panel A: C. pneumoniae clinical presentation - respiratory tract diagram showing pharyngitis with hoarseness as prodrome, followed by lower respiratory infection with prolonged cough (weeks-months duration noted), chest X-ray showing patchy infiltrates, and epidemiology note showing 5-10% of CAP cases with seroprevalence graph showing infection by age.
Panel B: C. psittaci and psittacosis - bird reservoir images (parrot, pigeon, turkey), transmission pathway showing inhalation of dried droppings or respiratory secretions, clinical features panel (high fever, severe headache, pneumonia, hepatosplenomegaly), and occupational risk icons (pet shop, veterinary, poultry processing).
Panel C: Diagnostic approach flowchart by species - C. trachomatis branch leading to NAAT (urine or swab, sensitivity/specificity noted), C. pneumoniae/C. psittaci branch leading to serology (acute and convalescent titers), with PCR increasingly available notation for all, and "culture rarely needed" crossed-out culture plate.
Panel D: Treatment regimen diagram - urogenital C. trachomatis (azithromycin 1g single dose or doxycycline 7 days), LGV (doxycycline 21 days), respiratory infections (azithromycin/doxycycline/fluoroquinolone), neonatal (erythromycin with "no doxycycline" note), and partner treatment importance emphasized.
---
### V. Rickettsia
Rickettsia species are small gram-negative bacteria that have evolved as obligate intracellular parasites transmitted between hosts by arthropod vectors, causing diseases characterized by vasculitis with significant morbidity and mortality if untreated. These organisms are difficult to visualize on standard Gram staining due to their small size (0.3-0.5 by 1-2 micrometers), though they possess a typical gram-negative cell wall structure and stain red with Giemsa or Gimenez techniques. Unlike Chlamydia, which remains within membrane-bound vacuoles, Rickettsia escapes from the phagosome into the host cell cytoplasm, where it replicates freely and eventually spreads to adjacent cells. The target cells for rickettsial infection are endothelial cells lining blood vessels, and the resulting endothelial damage produces the hallmark vasculitis responsible for most clinical manifestations including rash, edema, and organ dysfunction.
Rickettsial diseases are classified into major groups based on their epidemiology and clinical features. The spotted fever group includes Rocky Mountain spotted fever (RMSF) caused by Rickettsia rickettsii and numerous other species causing less severe spotted fevers in different geographic regions. The typhus group includes epidemic typhus caused by R. prowazekii transmitted by body lice during conditions of war and poverty, and endemic (murine) typhus caused by R. typhi transmitted by rat fleas in tropical and subtropical regions. Scrub typhus, caused by Orientia tsutsugamushi and transmitted by chigger mites, occurs throughout the Asia-Pacific region. Each disease shows characteristic geographic distribution reflecting vector ecology, and recognition of tick, louse, or flea exposure is essential for considering rickettsial disease in the differential diagnosis of febrile illness with rash.
Rocky Mountain spotted fever remains the most severe rickettsial disease in the Western Hemisphere, with mortality rates of 20-25% in untreated cases and significant mortality even with treatment when therapy is delayed. Despite its name, RMSF occurs predominantly in the southeastern and south-central United States, with highest incidence in North Carolina, Oklahoma, Arkansas, and Tennessee. Transmission occurs through the bite of infected dog ticks (Dermacentor variabilis in the east, D. andersoni in the west), with an incubation period of 2-14 days following tick attachment. The classic clinical triad includes fever, severe headache, and rash; however, this triad may not be present early in illness, and the rash may be absent or subtle in some cases. The characteristic rash begins on the wrists and ankles (peripheral distribution) and spreads centrally to the trunk, eventually becoming petechial or purpuric as endothelial damage progresses.
The diagnosis and treatment of RMSF exemplify the critical principle that empiric therapy must not await laboratory confirmation. Diagnostic testing typically involves serology using indirect immunofluorescence assay, but antibodies may not be detectable until the second week of illness, too late for meaningful clinical impact. PCR and immunohistochemistry of skin biopsy specimens can provide earlier confirmation but are not widely available. Consequently, the diagnosis is fundamentally clinical, based on the constellation of fever, headache, and rash in a patient with potential tick exposure during appropriate season and geography. Treatment with doxycycline should begin immediately upon clinical suspicion, as delay in therapy directly correlates with increased mortality. Importantly, doxycycline is recommended even for children despite general concerns about tetracycline effects on teeth, as the risk of death from untreated RMSF far outweighs the minimal risk from a short course of doxycycline.
Panel A: Rickettsia cellular biology - intracellular location diagram showing organism escaping phagosome to cytoplasm, replication in cytoplasmic environment, spread to adjacent cells by actin-based motility, and target cell identification (vascular endothelial cells with resulting vasculitis depicted as damaged vessel wall).
Panel B: Rickettsial disease classification chart - three columns for spotted fever group (RMSF, R. rickettsii, tick vector), typhus group (epidemic louse-borne and endemic flea-borne), and scrub typhus (Orientia, chigger mite), with geographic distribution maps for each group.
Panel C: RMSF clinical features - timeline from tick exposure through incubation (2-14 days) to symptom onset showing classic triad (fever, headache, rash), rash progression diagram showing peripheral to central spread (starting at wrists/ankles, spreading to trunk), and evolution from maculopapular to petechial.
Panel D: RMSF diagnostic and treatment paradigm - "DON'T WAIT" emphasized at center, serology timeline showing antibodies appearing too late (week 2), clinical diagnosis criteria listed (fever, headache, rash, tick exposure, geographic/seasonal), doxycycline bottle with "treat immediately" label, and mortality graph showing increased death with treatment delay.
---
### VI. Other Rickettsial Diseases
Epidemic typhus caused by Rickettsia prowazekii represents a classic disease of war, famine, and social disruption, transmitted by the human body louse that thrives under conditions of crowding and poor hygiene. Historical epidemics devastated military campaigns and civilian populations, with Napoleon's army in Russia suffering massive casualties from typhus. The louse becomes infected while feeding on a bacteremic human, and the organism multiplies within the louse's gut; infectious feces deposited during feeding are scratched into the bite wound or mucous membranes. Clinical features include abrupt onset of high fever, severe headache, and a rash that begins on the trunk and spreads centrifugally (opposite to RMSF). Brill-Zinsser disease represents reactivation of latent R. prowazekii infection years to decades after primary infection, typically presenting as a milder illness but potentially capable of initiating new outbreaks if louse exposure occurs.
Endemic (murine) typhus caused by R. typhi is transmitted by the rat flea and occurs worldwide in tropical and subtropical regions where rats and their fleas are abundant. Suburban areas with peridomestic rodent populations, including opossums and feral cats in addition to rats, maintain transmission cycles. The clinical presentation is generally milder than epidemic typhus, with fever, headache, and rash developing gradually. The rash typically begins on the trunk and spreads peripherally, helping distinguish it from RMSF. Most cases are self-limited, though severe complications can occur in elderly or immunocompromised patients. Treatment with doxycycline hastens recovery and prevents complications.
Ehrlichia and Anaplasma represent distinct genera of tick-transmitted intracellular bacteria that, unlike classical Rickettsia, target circulating leukocytes rather than endothelial cells. Ehrlichia chaffeensis causes human monocytic ehrlichiosis (HME), transmitted by the Lone Star tick in southeastern and south-central United States; the organism infects monocytes and macrophages. Anaplasma phagocytophilum causes human granulocytic anaplasmosis (HGA), transmitted by the same Ixodes tick that transmits Lyme disease and thus sharing similar geographic distribution in the northeastern and upper midwestern United States. Both diseases present with fever, headache, myalgias, and laboratory abnormalities including leukopenia, thrombocytopenia, and elevated liver enzymes. The diagnostic hallmark is identification of morulae, mulberry-like clusters of organisms within the cytoplasm of infected leukocytes on peripheral blood smear. Treatment with doxycycline is highly effective.
Coxiella burnetii causes Q fever, a disease that differs from other rickettsial infections in its primary transmission through inhalation of contaminated aerosols rather than arthropod vectors, though ticks can maintain environmental cycles. Livestock, particularly cattle, sheep, and goats, represent the primary reservoir, with massive quantities of organisms shed in birth products, placenta, and urine; unpasteurized dairy products represent an additional source. The organism forms a spore-like structure resistant to environmental stress, enabling airborne transmission over considerable distances from infected animals. Acute Q fever presents variably as a self-limited febrile illness, pneumonia, or granulomatous hepatitis, often without rash. Chronic Q fever, occurring in a minority of patients, most notably causes culture-negative endocarditis on previously abnormal heart valves, requiring prolonged (18-24 months) combination therapy with doxycycline and hydroxychloroquine.
Panel A: Epidemic typhus ecology - body louse life cycle on human host, wartime/famine conditions illustration, transmission mechanism (infected feces scratched into bite), clinical presentation (high fever, headache, centrifugal rash starting on trunk), and Brill-Zinsser disease as reactivation years later shown on timeline.
Panel B: Endemic typhus comparison - rat flea vector illustrated, suburban environment with rodents (rats, opossums), milder clinical presentation noted, rash pattern (trunk to periphery), and geographic distribution map showing tropical/subtropical zones.
Panel C: Ehrlichia and Anaplasma diagram - split panel showing E. chaffeensis (Lone Star tick, monocyte target, southeastern US map) and A. phagocytophilum (Ixodes tick, neutrophil target, northeastern US map), with morulae appearance in infected cells illustrated and shared clinical features (fever, leukopenia, thrombocytopenia, elevated LFTs) listed.
Panel D: Q fever unique features - inhalation transmission (not vector) with barn/livestock setting, Coxiella spore-like form enabling environmental persistence, acute manifestations (pneumonia, hepatitis, FUO), chronic endocarditis on prosthetic/abnormal valve, and treatment showing prolonged doxycycline plus hydroxychloroquine.
---
### VII. Mycoplasma and Ureaplasma
Mycoplasma species represent the smallest free-living organisms capable of self-replication, distinguished from all other bacteria by their complete lack of a cell wall. The absence of peptidoglycan has profound implications for both laboratory diagnosis and treatment: these organisms do not Gram stain (nothing to retain crystal violet), cannot be detected by standard culture techniques, and are inherently resistant to all beta-lactam antibiotics whose mechanism requires interference with cell wall synthesis. Instead of a rigid cell wall, mycoplasmas are bounded by a triple-layered membrane incorporating cholesterol derived from the host, providing sufficient structural integrity for survival. Their small genome and limited biosynthetic capabilities necessitate complex nutritional requirements for in vitro growth, including sterols that must be provided exogenously.
Mycoplasma pneumoniae causes respiratory tract infections ranging from pharyngitis and tracheobronchitis to pneumonia, representing a major cause of community-acquired pneumonia particularly in school-age children and young adults. The clinical presentation earned the historical designation "walking pneumonia" because patients typically remain ambulatory with illness too mild to warrant bed rest despite radiographic evidence of pneumonia. The onset is gradual with a prodrome of malaise, headache, and sore throat, followed by development of a persistent, dry, hacking cough that may continue for weeks. Physical examination often reveals findings disproportionately minimal compared to chest radiograph abnormalities. Extrapulmonary manifestations occur occasionally, including hemolytic anemia caused by cold agglutinins (IgM antibodies against the I antigen on erythrocytes that cause agglutination at cold temperatures), skin manifestations including Stevens-Johnson syndrome, and neurologic complications.
The clinical features of M. pneumoniae infection reflect the organism's interaction with respiratory epithelium and subsequent immune responses. The organism attaches to respiratory epithelial cells via specialized tip structures containing adhesin proteins, damaging ciliated cells and inducing inflammatory responses. The characteristic non-productive cough results from tracheobronchial inflammation without the abundant secretions of typical bacterial pneumonia. Cold agglutinins develop in approximately 50% of patients and can cause complement-mediated hemolytic anemia when agglutinated erythrocytes trigger the complement cascade; bedside testing by placing blood in a tube on ice demonstrates clumping at cold temperatures. Dermatologic manifestations range from maculopapular rashes to severe Stevens-Johnson syndrome with mucosal involvement. Neurologic complications including encephalitis, transverse myelitis, and Guillain-Barre syndrome occur rarely but can be severe.
Additional mycoplasmas and the related genus Ureaplasma cause urogenital infections and complications affecting reproductive health and neonatal outcomes. Mycoplasma hominis colonizes the genital tract and has been associated with pyelonephritis, pelvic inflammatory disease, and postpartum fever, though distinguishing colonization from infection can be difficult. Mycoplasma genitalium has emerged as an important cause of non-gonococcal urethritis in men and cervicitis in women, sometimes persisting despite standard chlamydia treatment due to frequent macrolide resistance. Ureaplasma urealyticum colonizes the genital tract of many adults and has been implicated in non-gonococcal urethritis, chorioamnionitis, and premature rupture of membranes, though its pathogenic role remains debated for some conditions. Treatment options for urogenital mycoplasmas include azithromycin and fluoroquinolones, with the important caveat that beta-lactam antibiotics are completely ineffective due to the absence of cell wall target.
Panel A: Mycoplasma cell structure - comparison diagram showing typical bacterium with cell wall versus Mycoplasma without wall, cholesterol-containing membrane illustrated with lipid bilayer structure, size comparison showing smallest free-living organism, and beta-lactam resistance mechanism (no peptidoglycan target for drug binding).
Panel B: M. pneumoniae respiratory infection - respiratory tract diagram showing attachment to ciliated epithelium via adhesin tip structures, clinical presentation icons (gradual onset, dry hacking cough, ambulatory patient despite CXR infiltrates), and "walking pneumonia" label with young adult demographic noted.
Panel C: Cold agglutinins and extrapulmonary manifestations - blood tube on ice showing RBC agglutination, IgM anti-I mechanism diagram, hemolytic anemia consequence, skin manifestations (maculopapular rash, Stevens-Johnson syndrome with mucosal involvement), and neurologic complications (brain icon with encephalitis, spinal cord with transverse myelitis).
Panel D: Urogenital mycoplasmas table - M. hominis (PID, postpartum fever), M. genitalium (urethritis, cervicitis, "macrolide resistance common" warning), Ureaplasma (urethritis, chorioamnionitis, PROM), with treatment options (azithromycin, fluoroquinolones) and "NOT beta-lactams" emphasized.
---
### VIII. Treponema pallidum (Syphilis)
Treponema pallidum subspecies pallidum causes syphilis, a sexually transmitted infection of global importance that remains prevalent despite the availability of highly effective treatment. This spirochete possesses a slender, tightly coiled morphology approximately 6-15 micrometers in length and 0.1-0.2 micrometers in width, too thin to be visualized by conventional light microscopy but visible by dark-field examination or fluorescent antibody staining. Remarkably, T. pallidum cannot be cultivated on any artificial medium, limiting research and necessitating reliance on serologic testing for diagnosis. Transmission occurs through direct contact with infectious lesions during sexual activity, through transplacental passage causing congenital syphilis, or rarely through blood transfusion or accidental inoculation. The organism penetrates intact mucous membranes or enters through breaks in skin, disseminating widely within hours of infection despite remaining localized clinically for weeks.
Primary syphilis manifests with the chancre, a painless ulcer appearing at the site of inoculation 10-90 days (average 21 days) after exposure. The classic chancre presents as a single, round or oval ulcer with a clean base, indurated (firm) edges, and nontender unless secondarily infected. Common locations include the genitalia, perianal region, and oral cavity, though chancres may occur at any site of intimate contact. The painless nature of the lesion often leads patients to ignore it or not notice it, particularly when located in sites not easily visualized. The chancre heals spontaneously within 3-6 weeks regardless of treatment, which does not indicate cure but rather progression to latent or secondary disease. Differential diagnosis includes herpes simplex virus (typically multiple painful vesicles/ulcers), chancroid (painful ulcer with purulent base), and lymphogranuloma venereum.
Secondary syphilis develops 4-10 weeks after the primary chancre, representing widespread dissemination with multisystem manifestations. The hallmark is a diffuse rash that characteristically involves the palms and soles, an unusual distribution that should prompt consideration of syphilis in any patient with palmar-plantar eruption. The rash varies in appearance from macular to papular to papulosquamous and is typically symmetric and non-pruritic. Condylomata lata are moist, raised, grayish-white, highly infectious plaques occurring in warm, moist areas including the perineum and axillae. Mucous patches appear as painless grayish erosions on oral or genital mucous membranes. Constitutional symptoms include low-grade fever, malaise, pharyngitis, generalized lymphadenopathy, and occasionally hepatitis, nephritis, or meningitis. Secondary syphilis resolves spontaneously within weeks but may recur.
Tertiary syphilis develops in approximately one-third of untreated patients years to decades after initial infection, manifesting as gummatous, cardiovascular, or neurologic disease. Gummas are granulomatous lesions with central necrosis that may affect any organ but commonly involve skin and bone, causing destructive lesions. Cardiovascular syphilis characteristically causes aortitis affecting the ascending aorta, leading to aortic aneurysm, aortic regurgitation, and coronary ostial stenosis. Neurosyphilis can occur at any stage but classic late manifestations include tabes dorsalis (posterior column degeneration causing sensory ataxia and lightning pains) and general paresis (progressive dementia with personality changes). Congenital syphilis results from transplacental transmission, with manifestations including early features (rhinitis, rash, hepatosplenomegaly) and late stigmata comprising Hutchinson's triad of Hutchinson teeth (notched central incisors), interstitial keratitis, and eighth nerve deafness.
Panel A: T. pallidum morphology and characteristics - dark-field microscopy image showing spiral organism, dimensions labeled (6-15 micrometers length, 0.1-0.2 micrometers width), "cannot culture in vitro" with crossed-out agar plate, transmission routes (sexual contact with lesion, vertical through placenta, blood), and rapid dissemination concept despite localized lesion.
Panel B: Primary syphilis chancre - typical genital chancre photograph/illustration showing clean-based ulcer with raised indurated edges, "painless" emphasized, locations marked on anatomic diagram, healing timeline (3-6 weeks without treatment), and differential diagnosis comparison (HSV: painful vesicles; chancroid: painful purulent base; LGV).
Panel C: Secondary syphilis manifestations - body diagram with rash distribution including palms and soles highlighted, condylomata lata in perineal region, mucous patches on oral mucosa, lymphadenopathy nodes, and systemic symptoms listed (fever, malaise, hepatitis, meningitis).
Panel D: Tertiary syphilis complications - three organ systems: gummatous (skin/bone destructive lesions), cardiovascular (aortitis leading to aneurysm and aortic regurgitation with anatomic illustration), and neurologic (tabes dorsalis with posterior column damage, general paresis with dementia); congenital syphilis panel showing Hutchinson triad (teeth, eyes, ears).
---
### IX. Other Spirochetes
Borrelia burgdorferi causes Lyme disease, the most common tick-borne infection in North America and Europe, transmitted by Ixodes ticks (deer ticks or black-legged ticks) whose expanding geographic range has increased disease incidence. The white-footed mouse serves as the primary reservoir maintaining infection in nature, while deer provide blood meals for adult ticks, supporting tick population expansion. Geographic distribution in the United States concentrates in the northeastern states (Connecticut to Maine), the upper Midwest (Minnesota, Wisconsin), and the Pacific coast (northern California, Oregon). Transmission requires prolonged tick attachment, typically 36-48 hours, providing a window for tick removal before infection occurs. The clinical course progresses through stages: early localized disease, early disseminated disease, and late disease, with manifestations reflecting the organism's ability to disseminate widely from the initial skin inoculation site.
The clinical manifestations of Lyme disease span multiple organ systems reflecting spirochetal dissemination and both direct tissue invasion and immunopathologic responses. Early localized disease presents with erythema migrans, an expanding erythematous patch with central clearing creating the classic "bull's eye" or target appearance, typically occurring 7-14 days after the tick bite. Early disseminated disease, developing days to weeks later, may include multiple erythema migrans lesions indicating hematogenous spread, cardiac involvement manifesting as varying degrees of heart block (most commonly first-degree AV block but sometimes requiring temporary pacing), and neurologic involvement including facial nerve palsy (cranial nerve VII), lymphocytic meningitis, and radiculopathy. Late Lyme disease, occurring months to years after infection, typically manifests as large-joint monoarthritis or oligoarthritis, particularly affecting the knee. Treatment varies by stage, with oral doxycycline or amoxicillin for early disease and intravenous ceftriaxone for neurologic involvement or advanced disease.
Borrelia recurrentis and related species cause relapsing fever, characterized by recurring episodes of fever separated by afebrile intervals, reflecting the organism's remarkable ability to evade immune responses through antigenic variation. Louse-borne relapsing fever caused by B. recurrentis occurs in epidemic form associated with conditions of poverty, overcrowding, and poor hygiene, similar to epidemic typhus. Tick-borne relapsing fever caused by various Borrelia species is endemic in the western United States, Africa, and other regions where soft ticks of the genus Ornithodoros reside in rustic cabins or rodent burrows. The clinical course involves abrupt onset of high fever lasting several days, followed by defervescence and an afebrile period, then recurrence of fever. Each febrile episode corresponds to a new antigenic variant of the organism escaping antibodies generated against the previous variant. Diagnosis is made by visualizing spirochetes on blood smear obtained during febrile episodes when spirochetemia is highest.
Leptospira species cause leptospirosis, a zoonotic infection transmitted through contact with water or soil contaminated by urine from infected animals, particularly rats and other rodents, livestock, and dogs. Organisms penetrate mucous membranes or skin abrasions during recreational or occupational water exposure, including swimming in contaminated ponds, wading through floodwaters, or working in sewers or rice paddies. The clinical spectrum ranges from mild influenza-like illness (the majority of cases) to severe Weil's disease with jaundice, acute kidney injury, and hemorrhage. Initial symptoms include abrupt fever, severe headache, myalgia (particularly affecting calves), and conjunctival suffusion (conjunctival redness without purulent discharge). Weil's disease represents severe leptospirosis with icteric hepatitis, renal failure, and hemorrhagic manifestations including pulmonary hemorrhage. Treatment with doxycycline or penicillin is effective and should be initiated when clinical suspicion exists.
Panel A: Lyme disease ecology and transmission - Ixodes tick life cycle (larva, nymph, adult), white-footed mouse as reservoir, deer supporting adult tick population, US map showing endemic regions (Northeast, Upper Midwest, Pacific coast), and transmission timeline showing 36-48 hours attachment needed for infection.
Panel B: Lyme disease clinical stages - three-panel progression: early localized (erythema migrans with central clearing "bull's eye" pattern, 7-14 days post-bite), early disseminated (multiple EM lesions, heart block EKG tracing, facial palsy illustration), late disease (swollen knee representing large-joint arthritis), with treatment annotations (doxycycline/amoxicillin for early, IV ceftriaxone for neuro/advanced).
Panel C: Relapsing fever pattern - temperature chart showing cyclical fevers (high spikes followed by afebrile periods), antigenic variation mechanism (antibodies against variant 1 neutralized, variant 2 emerges), blood smear showing visible spirochetes during febrile episode, and transmission modes (louse-borne epidemic versus tick-borne endemic).
Panel D: Leptospirosis epidemiology and features - transmission diagram (animal urine contaminating water, human exposure through water contact), clinical spectrum from mild flu-like illness to severe Weil's disease (jaundice, kidney failure, hemorrhage), characteristic findings (conjunctival suffusion, calf myalgia), and flood/occupational exposure settings illustrated.
---
### X. Diagnosis and Treatment Summary
The diagnostic approaches to atypical bacteria reflect their unique growth characteristics and the unavailability of routine culture for most species. Nucleic acid amplification tests (NAAT) have become the preferred method for C. trachomatis, offering high sensitivity and specificity with noninvasive specimen collection (urine or self-collected swabs). Serology using indirect immunofluorescence assay serves as the primary diagnostic modality for Rickettsia, Ehrlichia, and Anaplasma, with the important caveat that antibodies may not be detectable early in illness. Mycoplasma pneumoniae diagnosis increasingly relies on PCR, though serology and the classic cold agglutinin test remain useful in some settings. For spirochetes, the approach varies by organism: syphilis diagnosis employs a two-tier serologic algorithm, Lyme disease uses clinical recognition of characteristic findings supplemented by two-tier serology for uncertain cases, and leptospirosis diagnosis combines serology with culture or PCR of blood or urine.
Syphilis serology deserves particular attention given its complexity and the existence of two different screening algorithms. The traditional algorithm begins with a non-treponemal test (RPR or VDRL), which detects antibodies against cardiolipin released from damaged host cells and spirochetes. Positive non-treponemal tests are confirmed with a treponemal test (FTA-ABS or TP-PA), which detects antibodies specifically against T. pallidum antigens. Non-treponemal titers correlate with disease activity and decline following treatment, making them useful for monitoring treatment response. The reverse sequence algorithm, increasingly used in automated laboratory settings, screens with a treponemal test and confirms positive results with RPR. Treponemal tests typically remain positive for life regardless of treatment, creating the situation where successfully treated individuals show positive treponemal but negative non-treponemal results (serological scar).
Treatment of atypical bacteria follows predictable patterns based on their intracellular location and cell wall status. Doxycycline provides excellent activity against nearly all atypical bacteria including Chlamydia, Rickettsia, Ehrlichia, Mycoplasma, Borrelia, and Leptospira, making it the empiric treatment of choice for suspected rickettsial disease and an option for most other atypical infections. Macrolides (azithromycin, erythromycin) serve as first-line treatment for Chlamydia trachomatis and Mycoplasma pneumoniae and represent alternatives for patients who cannot take doxycycline. Fluoroquinolones provide coverage for Chlamydia and Mycoplasma respiratory infections and some urogenital infections. Syphilis stands apart from other atypical bacterial infections, responding to penicillin G administered parenterally; this remains the only proven effective treatment for syphilis, with no adequate substitutes for neurosyphilis or congenital syphilis in penicillin-allergic patients, necessitating desensitization when needed.
Special considerations for treatment in pregnancy require attention to fetal safety while ensuring adequate therapy for infections that may cause fetal harm. Doxycycline is contraindicated in pregnancy due to effects on fetal bone and teeth development. Azithromycin is considered safe and represents the treatment of choice for chlamydial infection in pregnancy. For syphilis in pregnancy, penicillin remains the only option proven to prevent congenital infection; penicillin-allergic pregnant women must undergo desensitization followed by penicillin treatment, as no alternatives adequately treat the fetus. Lyme disease in pregnancy is treated with amoxicillin rather than doxycycline. These considerations highlight the importance of screening for treatable infections during pregnancy and selecting gestational age-appropriate antimicrobials for documented infections.
Panel A: Diagnostic test selection guide - table format with organism in left column, preferred diagnostic test in right column: C. trachomatis (NAAT), C. pneumoniae/C. psittaci (serology/PCR), Rickettsia/Ehrlichia (serology IFA), Mycoplasma (PCR, serology, cold agglutinins), Treponema (dark-field, two-tier serology), Borrelia burgdorferi (clinical + two-tier serology), Leptospira (serology, culture/PCR).
Panel B: Syphilis serology algorithms - two parallel pathways: traditional (RPR/VDRL screen, if positive confirm with FTA-ABS/TP-PA) and reverse sequence (treponemal test screen, if positive confirm with RPR), with interpretation boxes explaining results (both positive = active or past infection, treponemal only positive = possible treated infection or false positive requiring additional testing).
Panel C: Treatment wheel by organism - circular diagram with drug classes in outer ring (doxycycline covering most, macrolides for Chlamydia/Mycoplasma, fluoroquinolones for respiratory, penicillin G for syphilis), organisms in spokes, and visual emphasis on doxycycline as broad coverage agent with penicillin as syphilis-specific.
Panel D: Pregnancy treatment considerations - pregnant woman silhouette with contraindicated drug (doxycycline) crossed out, safe alternatives by condition: Chlamydia (azithromycin), syphilis (penicillin G with "desensitize if allergic" note), Lyme (amoxicillin), and warning about untreated syphilis causing congenital infection.
---
## Summary
- Atypical bacteria share the common feature of not staining well with Gram stain and requiring specialized diagnostic approaches beyond routine culture
- Chlamydia species are obligate intracellular organisms alternating between infectious elementary bodies and replicating reticulate bodies; C. trachomatis causes STIs and trachoma, C. pneumoniae causes atypical pneumonia, C. psittaci causes psittacosis
- Rickettsia species are tick, flea, and louse-transmitted bacteria targeting endothelial cells to cause vasculitis; RMSF presents with rash spreading from periphery to center and requires immediate doxycycline without waiting for confirmation
- Ehrlichia and Anaplasma infect leukocytes producing characteristic morulae; both are treated with doxycycline
- Mycoplasma species lack cell walls and are inherently resistant to beta-lactam antibiotics; M. pneumoniae causes walking pneumonia with cold agglutinins
- Syphilis caused by T. pallidum progresses through primary (painless chancre), secondary (rash including palms/soles, condylomata lata), and tertiary stages (gumma, cardiovascular, neurosyphilis); penicillin is the only effective treatment
- Lyme disease caused by Borrelia burgdorferi presents with erythema migrans, may cause heart block and facial palsy, and late arthritis; treated with doxycycline or amoxicillin
- Leptospirosis is acquired through contaminated water exposure and ranges from mild flu-like illness to severe Weil's disease with jaundice and kidney failure
- Most atypical bacteria respond to doxycycline or macrolides; syphilis requires penicillin; doxycycline is avoided in pregnancy
---
## Key Terms
| Term | Definition |
|------|------------|
| Obligate intracellular | Organism that can only replicate within host cells, unable to survive or reproduce extracellularly |
| Elementary body | The infectious but metabolically inert form of Chlamydia adapted for extracellular survival |
| Reticulate body | The metabolically active, replicating form of Chlamydia found within host cell inclusion bodies |
| Morulae | Mulberry-like intracytoplasmic clusters of Ehrlichia or Anaplasma organisms visible in infected leukocytes |
| Spirochete | Bacterial morphology characterized by helical or spiral shape (Treponema, Borrelia, Leptospira) |
| Chancre | The painless ulcer with indurated edges that is the hallmark of primary syphilis |
| Erythema migrans | The expanding bull's eye or target lesion characteristic of early Lyme disease |
| Cold agglutinins | IgM antibodies against erythrocyte I antigen causing red blood cell agglutination at cold temperatures, associated with M. pneumoniae infection |
| Vasculitis | Inflammation of blood vessel walls caused by rickettsial infection of endothelial cells |
| Non-treponemal test | Syphilis serology detecting antibodies to cardiolipin (RPR, VDRL); correlates with disease activity |
---
*This content is subject to the [MIT License](https://opensource.org/licenses/MIT). © 2024–2026 Hibbert School of Medicine.*